PRECISION EPIGENOMICS Trademark

Trademark Overview


On Wednesday, November 1, 2023, a trademark application was filed for PRECISION EPIGENOMICS with the United States Patent and Trademark Office. The USPTO has given the PRECISION EPIGENOMICS trademark a serial number of 98250130. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 19, 2024. This trademark is owned by Precision Epigenomics, Inc.. The PRECISION EPIGENOMICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer

Cancer screening services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing services relating to the diagnosis and treatment of disease
precision epigenomics

General Information


Serial Number98250130
Word MarkPRECISION EPIGENOMICS
Filing DateWednesday, November 1, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer
Goods and ServicesCancer screening services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing services relating to the diagnosis and treatment of disease
NOT AVAILABLEEPIGENOMICS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2023
Primary Code005
First Use Anywhere DateThursday, April 18, 2024
First Use In Commerce DateThursday, April 18, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2023
Primary Code044
First Use Anywhere DateThursday, April 18, 2024
First Use In Commerce DateThursday, April 18, 2024

Trademark Owner History


Party NamePrecision Epigenomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Trademark Events


Event DateEvent Description
Wednesday, November 1, 2023NEW APPLICATION ENTERED
Friday, January 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 3, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, June 12, 2024ASSIGNED TO EXAMINER
Monday, September 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 16, 2024NON-FINAL ACTION WRITTEN
Monday, September 16, 2024NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED